What is NDC 71993-315?

71993-315 is the product NDC for Ranitidine, Ranitidine hydrochloride 300 mg/1 tablet, listed with the FDA by Atland Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Atland Pharmaceuticals, LLC, NDC labeler code 71993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranitidine?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranitidine NDC 71993-315 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71993-315Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71993-0315Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71993-315-30	71993031530	30 TABLET in 1 BOTTLE (71993-315-30)Marketed from Sep 19, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ranitidine
Generic name (nonproprietary): ranitidine
Active ingredients: Ranitidine hydrochloride — 300 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Atland Pharmaceuticals, LLCNDC labeler code 71993
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211289
Marketing start: Sep 18, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 71993-315_5c37b7e3-c3b4-67de-e063-6294a90a6680SPL ID 5c37b7e3-c3b4-67de-e063-6294a90a6680
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471993031530 followed by a unit qualifier and the quantity

Package 71993-0315-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 71993-315

What is NDC 71993-315?: 71993-315 is the product NDC for Ranitidine, Ranitidine hydrochloride 300 mg/1 tablet, listed with the FDA by Atland Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ranitidine.
What is the active ingredient?: Ranitidine hydrochloride.
Who is the labeler?: Atland Pharmaceuticals, LLC, NDC labeler code 71993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranitidine?: 12 other product NDCs are listed under this name. See all Ranitidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranitidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-314	71993-0314-30
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-636	64980-0636-03
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-637	64980-0637-03
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Granules India Ltd	62207-773	62207-0773-3662207-0773-4162207-0773-47+1 more
Ranitidine	Ranitidine hydrochloride 150 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-109	27241-0109-0627241-0109-50
Ranitidine	Ranitidine hydrochloride 300 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-110	27241-0110-0327241-0110-10
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-0727	00121-0727-16
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-4727	00121-4727-10
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	53746-253	53746-0253-0153746-0253-0553746-0253-10+2 more
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	53746-254	53746-0254-0153746-0254-0253746-0254-30

All 13 Ranitidine NDCs

Other NDCs under ANDA 211289

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211289
Product	Strength	Form · route	Labeler	Product NDC
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-636
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-637
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-314